Biomea Fusion, Inc.(BMEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BMEA Biomea Fusion, Inc.

Market Closed 05-15 16:00:00 EDT

1.35

-0.08

-5.59%

盘后1.37

+0.02+1.49%

19:50 EDT

High1.45	Low1.32	Vol1.91M
Open1.42	D1 Closing1.43	Amplitude9.04%
Mkt Cap97.60M	Tradable Cap91.05M	Total Shares72.30M
T/O2.61M	T/O Rate2.84%	Tradable Shares67.44M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BMEA","market":"US","secType":"STK","nameCN":"Biomea Fusion, Inc.","latestPrice":1.35,"timestamp":1778875200000,"preClose":1.43,"halted":0,"volume":1913877,"hourTrading":{"tag":"盘后","latestPrice":1.3701,"preClose":1.35,"latestTime":"19:50 EDT","volume":7386,"amount":10122.3095,"timestamp":1778889053612,"change":0.0201,"changeRate":0.014889,"amplitude":0.022519},"delay":0,"changeRate":-0.05594405594405584,"floatShares":67444700,"shares":72299440,"eps":-0.8547369,"marketStatus":"Market Closed","change":-0.08,"latestTime":"05-15 16:00:00 EDT","open":1.42,"high":1.4492,"low":1.32,"amount":2611396.9367703,"amplitude":0.09035,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.8547369,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779091200000},"marketStatusCode":7,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":1.43,"preHourTrading":{"tag":"盘前","latestPrice":1.42,"preClose":1.43,"latestTime":"09:28 EDT","volume":4899,"amount":7049.6737374,"timestamp":1778851681127,"change":-0.01,"changeRate":-0.006993,"amplitude":0.062727},"postHourTrading":{"tag":"盘后","latestPrice":1.3701,"preClose":1.35,"latestTime":"19:50 EDT","volume":7386,"amount":10122.3095,"timestamp":1778889053612,"change":0.0201,"changeRate":0.014889,"amplitude":0.022519},"volumeRatio":1.7737860891402095,"impliedVol":1.1761,"impliedVolPercentile":0.6932},"requestUrl":"/m/hq/s/BMEA","defaultTab":"news","newsList":[{"id":"2635840667","title":"Oppenheimer Keeps Their Buy Rating on Biomea Fusion (BMEA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635840667","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635840667?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:16","pubTimestamp":1778674618,"startTime":"0","endTime":"0","summary":"In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Biomea Fusion, with a price target of $9.00. According to T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-keeps-their-buy-rating-on-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-keeps-their-buy-rating-on-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMEA","OPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635405812","title":"Biomea Fusion to Participate at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2635405812","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635405812?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616300,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., May  12, 2026  (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that management ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293383/0/en/Biomea-Fusion-to-Participate-at-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BMEA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634253730","title":"Biomea Fusion Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2634253730","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634253730?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:44","pubTimestamp":1778535842,"startTime":"0","endTime":"0","summary":"Biomea Fusion Inc reports results for the quarter ended March 31 - Earnings SummaryBiomea Fusion Inc BMEA.OQ reported a quarterly adjusted loss of 17 cents per share for the quarter ended March 31, hi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O2PT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4585","BMEA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634253315","title":"Biomea Fusion Q1 EPS $(0.17) Beats $(0.24) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2634253315","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634253315?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:16","pubTimestamp":1778534185,"startTime":"0","endTime":"0","summary":"Biomea Fusion (NASDAQ:BMEA) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.24) by 29.17 percent. This is a 78.75 percent increase over losses of $(0.80) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52472216/biomea-fusion-q1-eps-0-17-beats-0-24-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Biomea Fusion Q1 EPS $(0.17) Beats $(0.24) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634258781","title":"Biomea Fusion Q1 net loss narrows as expenses fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2634258781","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634258781?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:05","pubTimestamp":1778533534,"startTime":"0","endTime":"0","summary":"Biomea Fusion Q1 net loss narrows as expenses fallOverviewUS diabetes and obesity drug developer's Q1 net loss narrowed yr/yrOperating expenses for Q1 fell sharply, driven by lower clinical activity a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL1N41O13Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BMEA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634525852","title":"Biomea Fusion Q1 FY26 net loss narrows to $12.4 million; cash falls to $45.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634525852","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634525852?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:55","pubTimestamp":1778532912,"startTime":"0","endTime":"0","summary":"Biomea Fusion posted a net loss attributable to common stockholders of USD 12.4 million, narrowing from USD 29.3 million a year earlier; loss per share improved to USD 0.17 from USD 0.80.R&D expense fell to USD 9.1 million from USD 22.9 million, due to lower external costs and personnel-related spending tied to reduced headcount.G&A expense dropped to USD 3.7 million from USD 6.8 million, on lower personnel-related and corporate costs.Cash, cash equivalents and restricted cash declined to USD 45.1 million as of March 31, 2026; cash runway projected into first quarter of 2027.Chronic toxicology studies completed for icovamenib to support dosing beyond 12 weeks; Phase II T2D trials COVALENT-211 and -212 began dosing with 26-week topline data expected in Q4 2026, while Phase I BMF-650 obesity study remained on track for initial 28-day weight data in Q2 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL9PK7Cx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BK4588","SG9999014005.SGD","NDAQ","BK4585","BK4139","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","BK4539","IE00B3QW5Z07.USD","BMEA","LU2095319765.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014021.USD","BK4112","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634258322","title":"Biomea Fusion Q1 Basic EPS USD -0.17","url":"https://stock-news.laohu8.com/highlight/detail?id=2634258322","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634258322?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:54","pubTimestamp":1778532891,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nPLX824F8E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BMEA","BK4585","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634258593","title":"Press Release: Biomea Fusion Reports First Quarter 2026 Financial Results and Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2634258593","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634258593?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:54","pubTimestamp":1778532840,"startTime":"0","endTime":"0","summary":"-- Successfully completed chronic toxicology studies for icovamenib,providing the nonclinical support for advancing to chronic clinical. dosing, beyond the 12-week clinical dosing that has been used to date. -- Topline data reported from the Phase II COVALENT-112 clinical trial of. icovamenib in type 1 diabetes , supporting proposed mechanism of. clinical trials of icovamenib in type 2 diabetes ; both trials are. on track with topline 26-week data expected in the fourth quarter of 2026. -- The Phase I GLP-131  obesity clinical trial is on track; initial. 28-day weight reduction data expected in the second quarter of 2026. Potential First-in-Class Oral Small Molecule Product Candidate Targeting Menin for Diabetes","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA","BK4139","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634461186","title":"U.S. Earnings Preview: After Market Close May 8","url":"https://stock-news.laohu8.com/highlight/detail?id=2634461186","media":"Dow Jones","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634461186?lang=en_us&edition=fundamental","pubTime":"2026-05-09 03:31","pubTimestamp":1778268660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.The following companies are among those expected to report their latest financial results after the market closes.Janus Henderson Group PLC's first-quarter EPS is forecast at 99 cents, compared with 77 cents in the prior-year period. Adjusted EPS is forecast at 96 cents.Radnet Inc.'s first-quarter EPS is forecast at a loss of 25 cents, compared with a loss of 51 cents in the prior-year period. Adjusted EPS is forecast at a loss of 16 cents.Hawaiian Electric Industries Inc.'s first-quarter EPS is forecast at 38 cents, compared with 15 cents in the prior-year period. Adjusted EPS is forecast at 27 cents.AnaptysBio Inc.'s first-quarter EPS is forecast at a loss of 74 cents, compared with a loss of $1.28 in the prior-year period. Adjusted EPS is forecast at a loss of 64 cents.Biomea Fusion Inc.'s first-quarter EPS is forecast at a loss of 28 cents, compared with a loss of 80 cents in the prior-ye","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BMEA","BK4135","BK4082","HE","RDNT","BK4585","LU2065731478.USD","BK4081","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","JHG","ANAB","IE00B64PRP62.GBP","BK4139","LU0054578231.USD","OBIO","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634508461","title":"Biomea Fusion options imply 18.9% move in share price post-earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2634508461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634508461?lang=en_us&edition=fundamental","pubTime":"2026-05-09 03:05","pubTimestamp":1778267138,"startTime":"0","endTime":"0","summary":"Pre-earnings options volume in Biomea Fusion (BMEA) is normal with calls leading puts 5:1. Implied volatility suggests the market is anticipating a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomea-fusion-options-imply-18-9-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomea-fusion-options-imply-18-9-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633116718","title":"Biomea Fusion options imply 23.1% move in share price post-earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2633116718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633116718?lang=en_us&edition=fundamental","pubTime":"2026-05-07 10:00","pubTimestamp":1778119217,"startTime":"0","endTime":"0","summary":"Pre-earnings options volume in Biomea Fusion (BMEA) is normal with calls leading puts 211:1. Implied volatility suggests the market is anticipating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomea-fusion-options-imply-23-1-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomea-fusion-options-imply-23-1-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633185480","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2633185480","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633185480?lang=en_us&edition=fundamental","pubTime":"2026-05-06 18:00","pubTimestamp":1778061600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Alpha & Omega                                   3Q      (.36)   4:01 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADMA","BBD","APO","BMEA","BKD","ARM","ALVO","AXON","AMPL","BLBD","AZTA","BBSI","BKH","ARQ","AGL","BTMD","BLLN","BWA","BRKR","CDLX","BCRX","ACVA","ALNT","CDW","ALB","ADNT","AUR","BYND","AUGO","BRLT","BVS","APA","ATO","BCO","BROS","ASTE","CDE","CF","ARRY","AMCR","BLMN","ARQT","ALLO","APP","AEVA","ATRA","AOSL","AMH","CGNX","ACAD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633892012","title":"Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions","url":"https://stock-news.laohu8.com/highlight/detail?id=2633892012","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633892012?lang=en_us&edition=fundamental","pubTime":"2026-05-06 05:50","pubTimestamp":1778017800,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., May  05, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/05/3288402/0/en/Biomea-Fusion-Announces-Poster-Presentations-of-Icovamenib-at-the-American-Diabetes-Association-ADA-86th-Scientific-Sessions.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4107","BMEA","BK4585","BK4117","AFG","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633338943","title":"Biomea Fusion Initiated at Market Outperform by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2633338943","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633338943?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:43","pubTimestamp":1777984980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BMEA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2026 08:43 ET (12:43 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633391811","title":"Biomea Fusion initiated with an Outperform at Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2633391811","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633391811?lang=en_us&edition=fundamental","pubTime":"2026-05-05 16:25","pubTimestamp":1777969512,"startTime":"0","endTime":"0","summary":"Citizens initiated coverage of Biomea Fusion (BMEA) with an Outperform rating and $9 price target The company is developing icovamenib, a covalent ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomea-fusion-initiated-with-an-outperform-at-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomea-fusion-initiated-with-an-outperform-at-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633796841","title":"Biomea Fusion options imply 22.0% move in share price post-earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2633796841","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633796841?lang=en_us&edition=fundamental","pubTime":"2026-05-05 03:15","pubTimestamp":1777922113,"startTime":"0","endTime":"0","summary":"Pre-earnings options volume in Biomea Fusion (BMEA) is normal with calls leading puts 4:1. Implied volatility suggests the market is anticipating a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomea-fusion-options-imply-22-0-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomea-fusion-options-imply-22-0-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632603625","title":"Biomea Fusion Inc  expected to post a loss of 24 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2632603625","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632603625?lang=en_us&edition=fundamental","pubTime":"2026-05-02 07:02","pubTimestamp":1777676531,"startTime":"0","endTime":"0","summary":"Biomea Fusion Inc  expected to post a loss of24cents a share - Earnings Preview Biomea Fusion Inc BMEA.OQ BMEA.O is expected to  show no change in quarterly revenue when it reports  results on May 4 (","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nL8N41E26S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA","BK4585","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632644739","title":"U.S. Earnings Preview: After Market Close May 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2632644739","media":"Dow Jones","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632644739?lang=en_us&edition=fundamental","pubTime":"2026-05-02 03:31","pubTimestamp":1777663860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.The following companies are among those expected to report their latest financial results after the market closes.AnaptysBio Inc.'s first-quarter EPS is forecast at a loss of 72 cents, compared with a loss of $1.28 in the prior-year period.Oric Pharmaceuticals Inc.'s first-quarter EPS is forecast at a loss of 31 cents, compared with a loss of 42 cents in the prior-year period. Adjusted EPS is forecast at a loss of 32 cents.Biomea Fusion Inc.'s first-quarter EPS is forecast at a loss of 28 cents, compared with a loss of 80 cents in the prior-year period. Adjusted EPS is forecast at a loss of 23 cents.Generated from Dow Jones Calendar Live with data from Dow Jones and Factset.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BMEA","BK4585","ANAB","BK4139","ORIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630585788","title":"Biomea Fusion Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2630585788","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630585788?lang=en_us&edition=fundamental","pubTime":"2026-04-28 22:42","pubTimestamp":1777387320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BMEA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 28, 2026 10:42 ET (14:42 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630585292","title":"Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY), Omnicell (OMCL) and Biomea Fusion (BMEA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2630585292","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630585292?lang=en_us&edition=fundamental","pubTime":"2026-04-28 22:41","pubTimestamp":1777387272,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Butterfly Network (BFLY), Omnicell (OMCL) and Biomea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-butterfly-network-bfly-omnicell-omcl-and-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-butterfly-network-bfly-omnicell-omcl-and-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0128526141.USD","OMCL","HCSG","BK4137","BK4588","XLV","LU0029874061.USD","BK4539","BK4082","BFLY","BK4167","BK4139","XBI","LABU","BMEA","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biomeafusion.com","stockEarnings":[{"period":"1week","weight":-0.1234},{"period":"1month","weight":-0.3147},{"period":"3month","weight":0.08},{"period":"6month","weight":0.0547},{"period":"1year","weight":-0.0559},{"period":"ytd","weight":0.0887}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.056},{"period":"3month","weight":0.0842},{"period":"6month","weight":0.1001},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.06322},{"month":2,"riseRate":0.4,"avgChangeRate":0.025302},{"month":3,"riseRate":0.4,"avgChangeRate":0.163799},{"month":4,"riseRate":0,"avgChangeRate":-0.156763},{"month":5,"riseRate":0.5,"avgChangeRate":0.110246},{"month":6,"riseRate":0.4,"avgChangeRate":0.081609},{"month":7,"riseRate":0.4,"avgChangeRate":-0.019311},{"month":8,"riseRate":0.8,"avgChangeRate":0.078281},{"month":9,"riseRate":0.4,"avgChangeRate":-0.012411},{"month":10,"riseRate":0.2,"avgChangeRate":-0.126858},{"month":11,"riseRate":0.4,"avgChangeRate":-0.034764},{"month":12,"riseRate":0.4,"avgChangeRate":-0.114655}],"exchange":"NASDAQ","name":"Biomea Fusion, Inc.","nameEN":"Biomea Fusion, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biomea Fusion, Inc.(BMEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biomea Fusion, Inc.(BMEA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biomea Fusion, Inc.,BMEA,Biomea Fusion, Inc.股票,Biomea Fusion, Inc.股票老虎,Biomea Fusion, Inc.股票老虎国际,Biomea Fusion, Inc.行情,Biomea Fusion, Inc.股票行情,Biomea Fusion, Inc.股价,Biomea Fusion, Inc.股市,Biomea Fusion, Inc.股票价格,Biomea Fusion, Inc.股票交易,Biomea Fusion, Inc.股票购买,Biomea Fusion, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biomea Fusion, Inc.(BMEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biomea Fusion, Inc.(BMEA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}